Chronic Arterial Responses to Overlapping Paclitaxel-Eluting Stents

Stone, 2004, A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease, N Engl J Med, 350, 221, 10.1056/NEJMoa032441 Stone, 2005, Comparison of a polymer-based paclitaxel-eluting stent with a bare metal stent in patients with complex coronary artery disease: a randomized controlled trial, JAMA, 294, 1215, 10.1001/jama.294.10.1215 Stone, 2006, Paclitaxel-eluting stents vs vascular brachytherapy for in-stent restenosis within bare-metal stents: the TAXUS V ISR randomized trial, JAMA, 295, 1253, 10.1001/jama.295.11.1253 Abizaid, 2006, Twelve-month outcomes with a paclitaxel-eluting stent transitioning from controlled trials to clinical practice (the WISDOM Registry), Am J Cardiol, 98, 1028, 10.1016/j.amjcard.2006.05.020 Colombo, 2003, Randomized study to assess the effectiveness of slow- and moderate-release polymer-based paclitaxel-eluting stents for coronary artery lesions, Circulation, 108, 788, 10.1161/01.CIR.0000086926.62288.A6 Dawkins, 2005, Clinical efficacy of polymer-based paclitaxel-eluting stents in the treatment of complex, long coronary artery lesions from a multicenter, randomized trial: support for the use of drug-eluting stents in contemporary clinical practice, Circulation, 112, 3306, 10.1161/CIRCULATIONAHA.105.552190 Finn, 2005, Differential response of delayed healing and persistent inflammation at sites of overlapping sirolimus- or paclitaxel-eluting stents, Circulation, 112, 270, 10.1161/CIRCULATIONAHA.104.508937 Wilson, 2007, Overlapping paclitaxel-eluting stents: long-term effects in a porcine coronary artery model, Cardiovasc Res, 76, 361, 10.1016/j.cardiores.2007.07.004 Chu, 2006, Comparison of clinical outcomes of overlapping sirolimus- versus paclitaxel-eluting stents in patients undergoing percutaneous coronary intervention, Am J Cardiol, 98, 1563, 10.1016/j.amjcard.2006.07.032 Aoki, 2005, “Full metal jacket” (stented length > or =64 mm) using drug-eluting stents for de novo coronary artery lesions, Am Heart J, 150, 994, 10.1016/j.ahj.2005.01.050 Weissman, 2007, Effect of the polymer-based, paclitaxel-eluting TAXUS Express stent on vascular tissue responses: a volumetric intravascular ultrasound integrated analysis from the TAXUS IV, V, and VI trials, Eur Heart J, 28, 1574, 10.1093/eurheartj/ehm174 Mintz, 2006, Intravascular ultrasound in the drug-eluting stent era, J Am Coll Cardiol, 48, 421, 10.1016/j.jacc.2006.04.068 Aoki, 2005, Peristent remodeling and neointimal suppression 2 years after polymer-based, paclitaxel-eluting stent implantation: insights from serial intravascular ultrasound analysis in the TAXUS II study, Circulation, 112, 3876, 10.1161/CIRCULATIONAHA.105.558601 Tanabe, 2004, Chronic arterial responses to polymer-controlled paclitaxel-eluting stents: comparison with bare metal stents by serial intravascular ultrasound analyses: data from the randomized TAXUS-II trial, Circulation, 109, 196, 10.1161/01.CIR.0000109137.51122.49 Mintz, 2001, A report of the American College of Cardiology Task Force on Clinical Expert Consensus Documents, J Am Coll Cardiol, 37, 1478, 10.1016/S0735-1097(01)01175-5 Petronio, 2007, Randomized comparison of sirolimus and paclitaxel drug-eluting stents for long lesions in the left anterior descending artery: an intravascular ultrasound study, J Am Coll Cardiol, 49, 539, 10.1016/j.jacc.2006.09.042 Mintz, 2003, Circulation, 108, 1295, 10.1161/01.CIR.0000091254.73351.D6 Minutello, 2006, Angiographic pattern of restenosis following implantation of overlapping sirolimus-eluting (Cypher) stents, Am J Cardiol, 97, 499, 10.1016/j.amjcard.2005.09.082 Burzotta, 2007, Outcome of overlapping heterogenous drug-eluting stents and of overlapping drug-eluting and bare metal stents, Am J Cardiol, 99, 364, 10.1016/j.amjcard.2006.08.039 Kang, 2007, Angiographic and intravascular ultrasound study of the effects of overlapping sirolimus- and paclitaxel-eluting stents: comparison with same drug-eluting overlapping stents, Int J Cardiol, 123, 12, 10.1016/j.ijcard.2006.11.104 Kawaguchi, 2008, Angiographic and 3D intravascular ultrasound assessment of overlapping bare metal stent and three different formulations of drug-eluting stents in patients with diabetes mellitus, Int J Cardiovasc Imaging, 24, 125, 10.1007/s10554-007-9235-7 Ichikawa, 2007, Angioscopic findings of delayed healing at sites of sirolimus-eluting stent overlap after 21-month implantation, Int J Cardiol Weissman, 2005, Polymer-based paclitaxel-eluting stents reduce in-stent neointimal tissue proliferation: a serial volumetric intravascular ultrasound analysis from the TAXUS-IV trial, J Am Coll Cardiol, 45, 1201, 10.1016/j.jacc.2004.10.078 Schwartz, 2006, Cypher versus Taxus stents: comparing inflammatory response in porcine coronary arteries, Am J Cardiol, 98 Pires, 2007, Sirolimus and paclitaxel provoke different vascular pathological responses after local delivery in a murine model for restenosis on underlying atherosclerotic arteries, Heart, 93, 922, 10.1136/hrt.2006.102244 Serruys, 2002, Intravascular ultrasound findings in the multicenter, randomized, double-blind RAVEL (RAndomized study with the sirolimus-eluting VElocity balloon-expandable stent in the treatment of patients with de novo native coronary artery Lesions) trial, Circulation, 106, 798, 10.1161/01.CIR.0000025585.63486.59 Balakrishnan, 2005, Strut position, blood flow, and drug deposition: implications for single and overlapping drug-eluting stents, Circulation, 111, 2958, 10.1161/CIRCULATIONAHA.104.512475 Farb, 1999, Pathology of acute and chronic coronary stenting in humans, Circulation, 99, 44, 10.1161/01.CIR.99.1.44 Farb, 2002, Morphological predictors of restenosis after coronary stenting in humans, Circulation, 105, 2974, 10.1161/01.CIR.0000019071.72887.BD Finn, 2007, Pathological correlates of late drug-eluting stent thrombosis: strut coverage as a marker of endothelialization, Circulation, 115, 2435, 10.1161/CIRCULATIONAHA.107.693739 Nicholls, 2006, Intravascular ultrasound in cardiovascular medicine, Circulation, 114, e55, 10.1161/CIRCULATIONAHA.106.637942 Schoenhagen, 2006, Determinants of arterial wall remodeling during lipid-lowering therapy: serial intravascular ultrasound observations from the Reversal of Atherosclerosis with Aggressive Lipid Lowering Therapy (REVERSAL) trial, Circulation, 113, 2826, 10.1161/CIRCULATIONAHA.105.585703 Nissen, 2004, Effect of antihypertensive agents on cardiovascular events in patients with coronary disease and normal blood pressure: the CAMELOT study: a randomized controlled trial, JAMA, 292, 2217, 10.1001/jama.292.18.2217 Okazaki, 2004, Early statin treatment in patients with acute coronary syndrome: demonstration of the beneficial effect on atherosclerotic lesions by serial volumetric intravascular ultrasound analysis during half a year after coronary event: the ESTABLISH Study, Circulation, 110, 1061, 10.1161/01.CIR.0000140261.58966.A4